Affinity of Alkylphosphocholines to Biological Membrane of Prostate Cancer: Studies in Natural and Model Systems
The effectiveness of two alkylphosphocholines (APCs), hexadecylphosphocholine (miltefosine) and erucylphosphocholine to combat prostate cancer has been studied in vitro with artificial cancerous membrane, modelled with the Langmuir monolayer technique, and on cell line (Du-145). Studies performed with the Langmuir method indicate that both the investigated drugs have the affinity to the monolayer mimicking prostate cancer membrane (composed of cholesterol:POPC = 0.428) and the drug-membrane interactions are stronger for erucylphosphocholine as compared to hexadecylphosphocholine. Moreover, both studied drugs were found to fluidize the model membrane, which may lead to apoptosis. Indeed, biological studies confirmed that in Du-145 cell line both investigated alkylphosphocholines cause cell death primarily by apoptosis while necrotic cells constitute only a small percentage of APC-treated cells.
KeywordsAlkylphosphocholines Model membrane Langmuir monolayers Prostate cancer
There are plethora of studies confirming that many chemicals, including drugs, dietary supplements or environmental pollutants affect cellular membrane properties, which can further influence on cell functioning. Most frequently observed effects include changes in membrane fluidity, permittivity or membrane lipids organisation/composition as recently reviewed by Tekpli et al. (2013). In consequence, membrane function can be altered, resulting either in improved cells functioning or their death.
Changes in membrane properties observed in vivo can be verified in model systems, which are advantageous—as compared to natural ones—of being simple and well-defined, contrary to highly variable and complex living systems. Moreover, models enable a systematic analysis of a selected phenomenon of interest, while living systems provide only a global view on a particular problem. Among various membrane models applied (reviewed in Hąc-Wydro and Dynarowicz-Łątka 2008; Chan and Boxer 1999), most popular are Langmuir monolayers (Hąc-Wydro and Dynarowicz-Łątka 2008; Maget-Dana 1999) and liposomes/vesicles (Kell 1981). The former benefit from easiness of precise control of such model membrane parameters as its molecular packing, lateral pressure and composition.
Consistent results have been found upon analysing the effect of various xenobiotics on both natural and model membranes. For example, the formation of transmembrane channels (pores) by polyene antibiotics (e.g. amphotericin B), causing cells lysis (De Kruijff and Demel, 1974), was confirmed by Langmuir monolayer experiments (Seoane et al. 1998, 1999), proving the existence of strong interactions between the antibiotic molecules and membrane sterols (mammalian—cholesterol and fungi—ergosterol), leading to the formation of surface complexes, being responsible for the formation of channels. Another example is the increase of membrane fluidity observed in cell lines after the administration of anticancer drug—edelfosine (Santa-Rita et al. 2004; Gajate and Mollinedo 2001), which was confirmed on model membranes, mimicking leukemic cells (Hąc-Wydro and Dynarowicz-Łątka 2010). Alteration of cell membrane fluidity was also reported for toxic elements, such as mercury (Garcia et al. 2005). Further studies using model membranes enabled to get insight into this issue more deeply (Broniatowski et al. 2010). Also, cyclodextrins were studied in Langmuir monolayers imitating biomembranes. Although cholesterol depletion from natural membranes by cyclodextrins has been well documented as reviewed in ref. Zidovetzki and Levitan 2007, experiments on model systems allowed to carry out research in a broader aspect and dispelled doubts regarding the ability of phospholipids complexation by cyclodextrins (Flasiński et al. 2010; Jablin et al. 2010). Another example concerns the competition between membrane sterols and phospholipids, observed both in vivo (Lange et al. 2009) and in vitro (Miñones et al. 2009) studies.
All these examples show that studies on artificial systems are very useful as they confirm findings observed in vivo and are complementary to research carried out on living organisms.
This paper is aimed at analysing the effect caused by new generation anticancer drugs—alkylphosphocholines (APCs)—on prostate tumour membrane. Alkylphosphocholines belong to second generation antitumour lipids (ATLs), originally derived from lysophosphatidylcholine, however, of simplified structure, in which the glycerol backbone is lacking and substituted for a simple alkyl chain (Unger et al. 1992), as exemplified by hexadecylphosphocholine (miltefosine) (Eibl and Unger 1990), octadecylphosphocholine, perifosine and erucylphosphocholine (Jendrossek et al. 2003). Alkylphosphocholines have been found to be effective on various tumours cell lines, including breast cancer (Clive et al. 1999), acute leukaemia, lymphoma, colorectal cancer, multiple myeloma (Vink et al. 2005; Li et al. 2010; Crul et al. 2002; Gajate and Mollinedo 2007), brain tumours (Rübel et al. 2006) and prostate cancer (Rudner et al. 2010).
It is well known that cellular membranes of healthy and cancer cells differ significantly. For example, studies on leukaemia cells showed that the cancerous membrane is more fluid as compared to that of normal cells, which results mainly from decreased total cholesterol and cholesterol-to-phospholipids molar ratio (Johnson and Robinson 1979) and increased percentage of unsaturated fatty acids acyl chains of the major membrane phospholipids (Agatha et al. 2001). Similar tendency was also observed for other cancerous cell lines (e.g. lung cancer) (Sok et al. 1999), however, for prostate (Freeman and Solomon 2004) the effect was opposite, i.e. malicious membrane was more rigid as it contained increased level of cholesterol.
This paper is pointed at studying the effect of two selected alkylphosphocholines, namely hexadecylphosphocholine (miltefosine, HePC) and erucylphosphocholine (ErPC), on model prostate cancerous membrane and on living cells. Investigations on model system were performed using the Langmuir monolayer technique (Gaines 1966), while studies on biological systems were performed on the prostate cancer cells derived from brain metastasis cells (DU 145).
The investigated antitumour alkylphosphocholines, hexadecylphosphocholine (HePC) and erucylphosphocholine (ErPC), both of >99 % purity, were obtained from Avanti Polar Lipids and Aeterna Zentaris GmbH, respectively. The following lipids, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, >99 % purity, purchased from Avanti Polar Lipids) and cholesterol (≥99 % purity, purchased from Sigma-Aldrich) were used to prepare model prostate cancerous membrane. All the studied substances were kept in closed bottles in the freezer and used without further purification.
Langmuir Monolayer Studies
The spreading solutions for Langmuir monolayers experiments were prepared by dissolving appropriate weights of substances in spectroscopic grade chloroform/methanol (9:1 v/v) mixture. Langmuir monolayers were obtained by spreading an aliquot of the above-mentioned solutions (concentration of ca. 0.5 ± 0.2 mg/mL) with a Hamilton microsyringe (precise to ±2 µL) onto the surface of ultrapure water (resistivity ≥18.2 MΩ cm, pH 5.6, produced by the Millipore system). Mixed solutions were obtained by mixing proper volumes of respective stock solutions. The film compression (with the barrier speed of 50 cm2/min) was initiated 5 min after spreading to ensure total evaporation of the solvent. The surface pressure-area (π–A) isotherms were obtained with a 611 Langmuir–Blodgett trough (Coventry, U.K.) (total area = 600 cm2) placed on an anti-vibration table. Surface pressure was measured within 0.1 mN/m using a Wilhelmy plate made from ashless chromatography paper. Although using a filter paper may provoke errors due to the adsorption of film molecules, and therefore other materials like glass (Petelska and Figaszewski 2009) or platinum plate (Juskowiak and Swiatkowska 2013) are also applied, however, for the investigated molecules this was not the case. The temperature of the aqueous subphase was held constant to 37 ± 0.1 °C) by a circulating water system from Julabo.
The π–A isotherms were recorded for binary cholesterol/POPC model membrane as well as for ternary cholesterol/POPC/APCs monolayers of various drug concentration. Each experiment was repeated two or three times to ensure high reproducibility of the obtained isotherms to ±1 Å2. The mean area per molecules (A 12) values were determined from the experimental π–A curves, and the compression modulus (C S −1 ) as well as the excess free energy of mixing (ΔG Exc) values were calculated.
DU-145 cells (the prostate cancer cells derived from brain metastasis) were cultured in RPMI 1640 medium supplemented with 10 % of foetal calf serum, 100 U/ml penicillin–streptomycin solution, 10 mM HEPES, 1 mM sodium pyruvate and 4.5 mg/ml glucose (Sigma-Aldrich, Steinheim, Germany) and conducted in a incubator at 37 °C and 5 % CO2.
Cells were incubated with staurosporine and APCs at a concentration of 12.5, 25 and 50 µM. Two different incubation times were applied (24 and 48 h) to observe time-dependent response. Two types of control cells were prepared: the negative one (cells untreated by any kinds of additional substances) and the positive one (cells treated by staurosporine at a concentration of 100 µM).
Determination of Cell Death
Cell death was analysed by fluorescence microscopy (Olympus BX51). Combined staining of the cells with Annexin V FITC to identify cells in which apoptosis has already been started and propidium iodide PI (Annexin V-FITC Apoptosis Detection Kit, Sigma-Aldrich) for the detection of necrotic cells was applied. Annexin V FITC and PI-positive cells were observed using U-MNB2 (excitement 470–490 nm) and U-MNG2 (excitement 530–550 nm) filters, respectively. Apoptotic and necrotic cells were quantified by cell counting in a population of approximately 10,000 cells. Each experiment was repeated three times independently. The Mann–Whitney U test was used to compare differences between groups (p < 0.05). Statistical analysis of the obtained data was performed using the Statistica software, version 8.0.
Results and Discussion
Influence of Alkylphosphocholines on Model Prostate Cancerous Membrane
The negative values of ΔG Exc suggest stabilising—from thermodynamic point of view—effect of both investigated APCs on the monolayer mimicking model membrane, and the presence of stronger interactions between the components in ternary mixtures (1–2–3) as compared to those existing in cholesterol/POPC model membrane (1–2). Therefore, it can be concluded that the incorporation of APCs is favourable for binary cholesterol/POPC monolayer, serving as a model of cancerous prostate membrane. Additionally, highly negative values of ΔG Exc for ErPC-containing films prove that the interaction with model membrane are stronger (ca. 3-times) for ErPC versus HePC.
Induction of Apoptosis by APCs: Biological Studies
As can be seen in Fig. 8, in a untreated sample the population of apoptotic and necrotic cells after 24 h was small and the fraction of living cells was approx 94 %. Drug treatment caused a noticeable increase of the apoptotic cells number with relatively low percentage of cells in necrotic stage. After treatment with the lowest drug concentrations (12.5 µM), the achieved results were comparable: necrosis at 5 %, early apoptosis at 20–25 % and late apoptosis at approximately 14 %.
For longer incubation time—48 h—the increase of the amount of apoptotic and necrotic cells was observed in relation to the shorter exposure time (both in untreated and APCs-treated cells). For APCs-treated cells, the number of cells undergoing apoptosis was as follows: early apoptosis ~27 at.%, late apoptosis~26 at.% for 12.5 µM, early apoptosis ~30 at.%, late apoptosis ~26–29 at.% for 25 µM and early apoptosis ~37–40 at.%, late apoptosis ~26–30 at.% for 50 µM. Likewise, the population of necrotic cells has changed only slightly (from 5 to 7 %). All the obtained results for each studied drug dose and incubation time were statistical significant (p < 0.05) in comparison to the control untreated group.
Model studies carried out with the Langmuir monolayer technique unambiguously prove that both investigated APCs interact with a monolayer mimicking prostate cancer membrane. The observed effect is two-fold. Namely, the thermodynamic analysis based on ΔG Exc calculations evidences for the existence of strong drug-membrane interactions. The magnitude of the ΔG Exc values proves that ErPC has a higher affinity to a model membrane as compared to HePC. Therefore, one could expect that ErPC has more effective therapeutic effect. Moreover, both studied drugs were found to fluidize the model membrane. A plethora of studies performed on living systems, reviewed in ref. Tekpli et al. 2013, confirm that a change of cellular membrane elastic properties frequently leads to apoptosis. Indeed, biological studies confirmed that in Du-145 cell line APCs cause cell death primarily by apoptosis while necrotic cells constitute only a small percentage of APC-treated cells. An application of combined staining with Annexin V FITC and propidium Iodide allowed for a rapid, simultaneous detection of cells in early apoptotic stage (still alive) and late apoptosis stage (already death). To the best of our knowledge, this combination of biochemical stainings was applied for the first time in Du-145 cell death detection after APCs treatment. The results indicate an increase of therapeutic effect, which is associated with prolonged drug incubation time and the use of higher drug concentration. It was proved that ErPC is the most potent drugs of the investigated APCs, inducing apoptosis in DU-145 cells, which was inferred from the Langmuir monolayer studies. Additionally, investigations on cell lines prove that ErPC is a fast-acting drug in comparison with HePC. Just 24 h incubation with 50 µM ErPC inducted apoptosis in approx. 70 % of the population.
Aeterna Zentaris GmbH (Frankfurt, Germany) is gratefully acknowledged for providing a sample of erucylphosphocholine for investigations. The research was carried out with the equipment (Langmuir trough) purchased thanks to the financial support of the European Regional Development Fund in the framework of the Polish Innovation Economy Operational Programme (contract no. POIG.02.01.00-12-023/08). The financial support from the National Science Centre (NCN, Poland, Grant no. UMO-2012/07/N/NZ1/00005) is gratefully acknowledged.
- Broniatowski M, Flasiński M, Dynarowicz-Łątka P, Majewski J (2010) Grazing Incidence Diffraction and X-ray reflectivity studies of the interactions of inorganic mercury salts with membrane lipids in Langmuir monolayers at the air/water interface. J Phys Chem B 114:9474–9484CrossRefPubMedGoogle Scholar
- Crul M, Rosing H, de Klerk GJ, Dubbelman R, Traiser M, Reichert S, Knebel NG, Schellens JH, Beijnen JH, ten Bokkel Huinink WW (2002) Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours. Eur J Cancer 38:1615–1621CrossRefPubMedGoogle Scholar
- Davies JT, Rideal EK (1963) Interfacial Phenomena. Academic Press, New York and LondonGoogle Scholar
- Gaines GL Jr (1966) Insoluble monolayers at liquid–gas interfaces. Interscience, New YorkGoogle Scholar
- Hąc-Wydro K, Dynarowicz-Łątka P (2008) Biomedical applications of the Langmuir monolayer technique. Annales UMCS Ser AA (Chemia) 63:47–60Google Scholar
- Kell DB (1981) Are liposomes good models for biomembranes? Trends Biochem Sci 6:8–9Google Scholar
- Rübel A, Handrick R, Lindner LH, Steiger M, Eibl H, Budach W, Belka C, Jendrossek V (2006) The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro. Radiat Oncol 1:1–17CrossRefGoogle Scholar
- Ruiz-Garcia J (2006) Direct observations of phase changes in Langmuir films of cholesterol. Rev Mex Fis 52:32–40Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.